How safe are GLP-1R agonists in early pregnancy?

JAMA Internal Medicine study examines the safety of GLP-1 receptor agonists and other second-line antidiabetic medications during early pregnancy, finding no significant increase in congenital anomalies compared to insulin use.

FDA: Avoid Wegovy, Ozempic During Pregnancy

Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force

Semaglutide - Wikipedia

Metformin Chemistry

Frontiers Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence

GLP-1 For Weight Loss: Is It Safe? - Nutrisense Journal

d2jx2rerrg6sh3.cloudfront.net/image-handler/pictur

Sulfonylurea News, Research

Endocrines, Free Full-Text

Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review, BMC Endocrine Disorders

Targeting the GLP-1 Receptor: Genetics and a New Option for Weight Loss

Sulfonylurea News, Research

GIP Receptor Agonism Attenuates GLP-1 Receptor Agonist Induced Nausea and Emesis in Preclinical Models — Hayes Lab

Considerations about the role of GLP-1 receptor agonists in the